Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody Response”

636 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 636 results

Not applicableStudy completedNCT06607809
What this trial is testing

Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Dr. Lutfi Kirdar Kartal Training and Research Hospital 99
Not applicableUnknownNCT05745948
What this trial is testing

COVID-19 ANtibody Responses in Cystic Fibrosis: CAR-CF

Who this might be right for
COVID-19Cystic Fibrosis
Hospital Universitari Vall d'Hebron Research Institute 150
Early research (Phase 1)Study completedNCT04408963
What this trial is testing

Trial to Evaluate CAP256V2LS in Healthy Adults

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Ended earlyNCT01248455
What this trial is testing

A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma

Who this might be right for
Multiple MyelomaMyelomaSmoldering Multiple Myeloma
National Cancer Institute (NCI) 9
Not applicableStudy completedNCT02126384
What this trial is testing

Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response

Who this might be right for
Pneumococcal Diseases
Institut National de la Santé Et de la Recherche Médicale, France 9
Post-approval studies (Phase 4)Study completedNCT00708747
What this trial is testing

Biseko Versus Albumin in Systemic Inflammatory Response Syndrome (SIRS) Patients

Who this might be right for
Systemic Inflammatory Response Syndrome
Medical University of Vienna 40
Large-scale testing (Phase 3)Study completedNCT02662985
What this trial is testing

Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 166
Post-approval studies (Phase 4)Study completedNCT03294135
What this trial is testing

The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

Who this might be right for
Virus Diseases
GlaxoSmithKline 194
Testing effectiveness (Phase 2)UnknownNCT04036526
What this trial is testing

A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine

Who this might be right for
Whooping Cough
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT04871191
What this trial is testing

Study of Salvage Therapy to Treat Patients with Granulomatosis with Polyangiitis

Who this might be right for
Granulomatosis with PolyangiitisAnti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Assistance Publique - Hôpitaux de Paris 42
Not applicableUnknownNCT05009888
What this trial is testing

COVID-19 SARS-CoV-2 Antibody Testing Study

Who this might be right for
Healthy
King's College London 400
Not applicableLooking for participantsNCT06968442
What this trial is testing

The Role of Obesity in Severe COVID-19 Pathophysiology

Who this might be right for
COVID-19Antibody COVID-19
Franciscus Gasthuis 60
Not applicableStudy completedNCT05123742
What this trial is testing

PREDICT: A PBRN Feasibility Study on COVID-19 Screening in Dental Practice

Who this might be right for
COVID-19 Infection
Rutgers, The State University of New Jersey 72
Not applicableStudy completedNCT00357071
What this trial is testing

Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases

Who this might be right for
Eye Diseases
National Eye Institute (NEI) 219
Post-approval studies (Phase 4)Study completedNCT00310687
What this trial is testing

Persistence of Immune Response After Vaccination With MCC

Who this might be right for
Prevention of Meningococcal Infection
Novartis 1,244
Testing effectiveness (Phase 2)Looking for participantsNCT07259226
What this trial is testing

Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers

Who this might be right for
Advanced Breast CancerAdvanced Gastric CancerAdvanced Urothelial Cancer+1 more
UNICANCER 400
Testing effectiveness (Phase 2)Study completedNCT00784147
What this trial is testing

Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1

Who this might be right for
HIV
TaiMed Biologics Inc. 113
Not applicableActive Not RecruitingNCT02226276
What this trial is testing

Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer

Who this might be right for
Bone MetastasesHER2-positive Breast CancerLiver Metastases+4 more
City of Hope Medical Center 10
Not applicableUnknownNCT01272440
What this trial is testing

A Drug Monitoring Study on PEG-asparaginase Treatment in Children Diagnosed Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic Leukaemia
Aarhus University Hospital 200
Early research (Phase 1)Ended earlyNCT03859687
What this trial is testing

Trial of Antibody Responses by Vitamin Supplementation

Who this might be right for
Healthy Participants
St. Jude Children's Research Hospital 22
Load More Results